Biophytis S.A. (ALBPS.PA)
EUR 0.17
(0.41%)
EUR 0.17
(0.41%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -12.55 EUR | 77.61% |
| 2022 | -56.06 EUR | 46.93% |
| 2021 | -105.64 EUR | 38.73% |
| 2020 | -172.41 EUR | 61.78% |
| 2019 | -451.10 EUR | -6.43% |
| 2018 | -423.85 EUR | 18.26% |
| 2017 | -518.55 EUR | 2.21% |
| 2016 | -530.27 EUR | -21.62% |
| 2015 | -436.00 EUR | -760.98% |
| 2014 | -50.64 EUR | -35.95% |
| 2013 | -37.25 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.83 EUR | 0.0% |
| 2024 Q1 | -0.83 EUR | 67.7% |
| 2023 Q2 | -4.75 EUR | 0.0% |
| 2023 Q3 | -2.57 EUR | 45.89% |
| 2023 FY | - EUR | -9546.15% |
| 2023 Q4 | -2.57 EUR | 0.0% |
| 2023 Q1 | -4.75 EUR | 62.15% |
| 2022 Q2 | -16.80 EUR | 0.0% |
| 2022 Q1 | -16.80 EUR | 41.11% |
| 2022 FY | - EUR | 53.57% |
| 2022 Q3 | -12.55 EUR | 25.3% |
| 2022 Q4 | -12.55 EUR | 0.0% |
| 2021 Q4 | -28.53 EUR | 0.0% |
| 2021 FY | - EUR | 22.22% |
| 2021 Q1 | -24.08 EUR | 17.28% |
| 2021 Q2 | -24.08 EUR | 0.0% |
| 2021 Q3 | -28.53 EUR | -18.48% |
| 2020 Q4 | -29.11 EUR | 0.0% |
| 2020 Q1 | -74.45 EUR | 14.89% |
| 2020 Q3 | -29.11 EUR | 60.9% |
| 2020 Q2 | -74.45 EUR | 0.0% |
| 2020 FY | - EUR | 65.71% |
| 2019 Q1 | -112.94 EUR | 12.88% |
| 2019 FY | - EUR | 0.0% |
| 2019 Q4 | -87.48 EUR | 0.0% |
| 2019 Q3 | -87.48 EUR | 55.39% |
| 2019 Q2 | -196.09 EUR | -73.62% |
| 2018 Q3 | -129.64 EUR | -53.57% |
| 2018 Q2 | -84.42 EUR | 4.07% |
| 2018 Q1 | -88.00 EUR | 22.94% |
| 2018 FY | - EUR | 15.32% |
| 2018 Q4 | -129.64 EUR | 0.0% |
| 2017 Q2 | -147.44 EUR | 0.0% |
| 2017 Q3 | -114.20 EUR | 22.54% |
| 2017 Q4 | -114.20 EUR | 0.0% |
| 2017 FY | - EUR | 3.13% |
| 2017 Q1 | -147.44 EUR | -4.47% |
| 2016 Q4 | -141.13 EUR | 0.0% |
| 2016 Q3 | -141.13 EUR | -13.81% |
| 2016 Q1 | -124.00 EUR | 0.83% |
| 2016 FY | - EUR | -88.24% |
| 2016 Q2 | -124.00 EUR | 0.0% |
| 2015 Q1 | -61.82 EUR | -351.9% |
| 2015 Q2 | -61.82 EUR | 0.0% |
| 2015 Q4 | -125.04 EUR | 0.0% |
| 2015 FY | - EUR | -5662.71% |
| 2015 Q3 | -125.04 EUR | -102.26% |
| 2014 Q4 | -13.68 EUR | 0.0% |
| 2014 Q2 | -11.64 EUR | 0.0% |
| 2014 Q1 | -11.64 EUR | 0.0% |
| 2014 FY | - EUR | -35.63% |
| 2014 Q3 | -13.68 EUR | -17.53% |
| 2013 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ABIONYX Pharma SA | -0.12 EUR | -10358.333% |
| ABIVAX Société Anonyme | -3.43 EUR | -265.889% |
| Adocia SA | -1.91 EUR | -557.068% |
| Aelis Farma SA | -0.39 EUR | -3117.949% |
| Advicenne S.A. | -0.67 EUR | -1773.134% |
| genOway Société anonyme | 0.17 EUR | 7482.353% |
| IntegraGen SA | -0.03 EUR | -48355.598% |
| Medesis Pharma S.A. | -0.80 EUR | -1468.75% |
| Neovacs S.A. | -0.00 EUR | -501900.0% |
| NFL Biosciences SA | -0.46 EUR | -2628.261% |
| Plant Advanced Technologies SA | 0.07 EUR | 18028.571% |
| Quantum Genomics Société Anonyme | -0.09 EUR | -13691.209% |
| Sensorion SA | -0.17 EUR | -7282.353% |
| Theranexus Société Anonyme | -0.88 EUR | -1326.136% |
| TME Pharma N.V. | -1.34 EUR | -836.567% |
| Valbiotis SA | -0.59 EUR | -2027.119% |
| TheraVet SA | -0.49 EUR | -2461.224% |
| Valerio Therapeutics Société anonyme | -0.15 EUR | -8266.667% |
| DBV Technologies S.A. | -0.71 EUR | -1667.606% |
| Genfit S.A. | -0.58 EUR | -2063.793% |
| GeNeuro SA | -0.59 EUR | -2027.119% |
| Innate Pharma S.A. | -0.09 EUR | -13236.876% |
| Inventiva S.A. | -2.43 EUR | -416.461% |
| MaaT Pharma SA | -1.73 EUR | -625.434% |
| MedinCell S.A. | -0.88 EUR | -1326.136% |
| Nanobiotix S.A. | -1.08 EUR | -1062.037% |
| OSE Immunotherapeutics SA | -1.18 EUR | -963.559% |
| Poxel S.A. | -0.91 EUR | -1279.121% |
| GenSight Biologics S.A. | -0.54 EUR | -2224.074% |
| Transgene SA | -0.22 EUR | -5604.545% |
| Valneva SE | -0.73 EUR | -1619.178% |